Due to their similarity and recent evidence that RBM10 mutates in up to 21% of lung cancer, majority of studies hypothesized that RBM10 has the tumor suppressive properties of RBM5 in small cell lung cancer. Here, RBM5 is linked to small cell lung carcinoma.